Study Details

Back
Study ID OSI-906-102
Study Title A Phase 1 Dose Escalation Study of Intermittent Oral OSI-906 Dosing in Patients with Advanced Solid Tumors
Clinicaltrials.gov Identifier NCT00514306
Compound Name ASP7487 / OSI-906 / linsitinib
Medical Indication or Disease Solid tumors
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 05-Jul-2007
Study Completion Date 20-Sep-2010
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS